Detalhe da pesquisa
1.
MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer.
Int J Cancer
; 139(4): 890-8, 2016 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26950035